News

23 June 2021

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story

10 June 2021

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story

9 June 2020

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story

9 June 2020

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story

1 June 2018

Pharma’s New R&D Models: Federating Innovation with Paul Stoffels M.D.

Read full story